ZERIA Pharmaceutical Licenses Gastric Ulcer Drug to SK Chemicals.Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, Mar 2, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - ZERIA Pharmaceutical announced on March 2 that it had concluded a licensing agreement with Korean company SK Chemicals as of February 27. Under the terms of the agreement, SK Chemicals is licensed to develop and sell Promac Granules Granules Small packets of reactive chemicals stored within cells. Mentioned in: Allergic Rhinitis, Allergies 15%, ZERIA's proprietary ethical agent for the treatment of gastric ulcers gastric ulcer n. An ulcer in the mucous membrane of the stomach. gastric ulcer A hole in gastric mucosa due to gastric secretions, related to H pylori in the mucosa, NSAIDs, cigarette smoking etc; the pain of a GU may , exclusively in Korea. Co-developed with Osaka-based pharmaceutical company Hamari Chemicals, Promac has been marketed in Japan since 1994. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion